Loading clinical trials...
Loading clinical trials...
To evaluate if the combination of psoralen plus ultraviolet A and narrowband ultraviolet B is more effective than narrowband ultraviolet B alone in the treatment of vitiligo.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Henry Ford Health System
NCT07533019 · Vitiligo, Non-Segmental Vitiligo (NSV)
NCT07431177 · Non-segmental Vitiligo
NCT07352293 · Vitiligo
NCT07353801 · Vitiligo
NCT07437560 · NonSegmental Vitiligo, Nonsegmental Vitiligo (Stable)
Henry Ford Dermatology
Detroit, Michigan
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions